Results
26,449 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 38 | Ives Glen RPresident, Chief Executive Officer |  CTMCastellum, Inc.Open-market purchase | BUY | $6,649 10.0K sh | Mar 26, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 38 | Ives Glen RPresident, Chief Executive Officer | CTMCastellum, Inc. Open-market purchase | BUY | $6,649 10.0K sh | Mar 26, 2026 |
| 37 | Yu SiyingGeneral Counsel |  BABAAlibaba Group Holding LtdOpen-market sale | SELL | $345K 21.5K sh | Mar 26, 2026 traded Mar 25, 2026 |
| 37 | Jiang FangChief People Officer | BABAAlibaba Group Holding Ltd Open-market sale | SELL | $271K 16.8K sh | Mar 26, 2026 traded Mar 25, 2026 |
| 36 | Soteropoulos PaulaDirector |  DNTHDianthus Therapeutics, Inc. /DE/Open-market sale · 10b5-1 plan | SELL | $2.15M 27.6K sh | Mar 26, 2026 traded Mar 24, 2026 |
| 35 | Nithrakashyap ArvindDirector, Chief Technology Officer |  RBRKRubrik, Inc.Open-market sale | SELL | $1.40M 29.0K sh | Mar 26, 2026 traded Mar 24, 2026 |
| 35 | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER |  ACADACADIA PHARMACEUTICALS INCOpen-market sale | SELL | $69K 3,171 sh | Mar 26, 2026 traded Mar 26, 2026 |
| 34 | Mandanas Mary BethDirector |  NRGVEnergy Vault Holdings, Inc.Open-market purchase | BUY | $18K 5,000 sh | Mar 26, 2026 traded Mar 25, 2026 |
| 32 | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER | ACADACADIA PHARMACEUTICALS INC Open-market sale | SELL | $804 37 sh | Mar 26, 2026 traded Mar 26, 2026 |
| 32 | Li Jeffrey KSVP and Secretary |  KEYSKeysight Technologies, Inc.Open-market sale | SELL | $594K 2,000 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 32 | Kihara JamesPRINCIPAL ACCOUNTING OFFICER | ACADACADIA PHARMACEUTICALS INC Open-market sale | SELL | $261 12 sh | Mar 26, 2026 traded Mar 26, 2026 |
| 32 | Kihara JamesPRINCIPAL ACCOUNTING OFFICER | ACADACADIA PHARMACEUTICALS INC Open-market sale | SELL | $18K 833 sh | Mar 26, 2026 traded Mar 25, 2026 |
| 32 | Kihara JamesPRINCIPAL ACCOUNTING OFFICER | ACADACADIA PHARMACEUTICALS INC Open-market sale | SELL | $24K 1,097 sh | Mar 26, 2026 traded Mar 26, 2026 |
| 32 | Choudary Kiran KumarChief Financial Officer | RBRKRubrik, Inc. Open-market sale | SELL | $5.91M 122.6K sh | Mar 26, 2026 traded Mar 24, 2026 |
| 31 | Halter Timothy PDirector |  DXPEDXP ENTERPRISES INCOpen-market sale | SELL | $698K 5,000 sh | Mar 26, 2026 traded Mar 26, 2026 |
| 31 | Flores JessicaExecutive VP & CAO |  SBRASabra Health Care REIT, Inc.Open-market sale | SELL | $302K 15.2K sh | Mar 26, 2026 traded Mar 25, 2026 |
| 31 | Zitkus LesterSVP, Land |  GPORGULFPORT ENERGY CORPOpen-market sale | SELL | $401K 1,873 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 30 | Balcom AlexandraChief Financial Officer |  NUVLNuvalent, Inc.Open-market sale · 10b5-1 plan | SELL | $735K 7,671 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 29 | Balcom AlexandraChief Financial Officer | NUVLNuvalent, Inc. Open-market sale · 10b5-1 plan | SELL | $1.37M 13.7K sh | Mar 26, 2026 traded Mar 25, 2026 |
| 29 | Finn Mark StevenDirector |  BBSIBARRETT BUSINESS SERVICES INCOpen-market purchase | BUY | $29K 1,000 sh | Mar 26, 2026 traded Mar 26, 2026 |
| 29 | Tonnel David AChief Accounting Officer |  SMRNUSCALE POWER CorpOpen-market sale | SELL | $27K 2,290 sh | Mar 26, 2026 traded Mar 25, 2026 |
| 29 | Balbirnie Brian RDirector, Director, CEO, 10% Owner |  ACCSACCESS Newswire Inc.Open-market purchase | BUY | $26K 3,396 sh | Mar 26, 2026 traded Mar 25, 2026 |
| 28 | Dhanasekaran SatishDirector, President and CEO | KEYSKeysight Technologies, Inc. Open-market sale | SELL | $500K 1,667 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 28 | Ghodoosi ArashPresident, Principal Executive |  XIVYXInstitutional Investment Strategy FundOpen-market purchase | BUY | $10 1 sh | Mar 26, 2026 traded Mar 23, 2026 |
| 28 | Morais Silvio JoseDirector |  STNEStoneCo Ltd.Open-market sale | SELL | $97K 6,800 sh | Mar 26, 2026 traded Mar 25, 2026 |
| 28 | Murphy Matthew JDirector, Chairman of the Board and CEO |  MRVLMarvell Technology, Inc.Open-market sale · 10b5-1 plan | SELL | $2.96M 30.0K sh | Mar 26, 2026 traded Mar 26, 2026 |
| 25 | Owens Bradley D.General Counsel |  ZANDZGZILLOW GROUP, INC.Open-market sale · 10b5-1 plan | SELL | $384K 8,800 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 23 | Balcom AlexandraChief Financial Officer | NUVLNuvalent, Inc. Open-market sale · 10b5-1 plan | SELL | $112K 1,160 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 23 | Balcom AlexandraChief Financial Officer | NUVLNuvalent, Inc. Open-market sale · 10b5-1 plan | SELL | $247K 2,599 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 22 | Rubinstein JuliePresident and COO |  ADPTAdaptive Biotechnologies CorpOpen-market sale · 10b5-1 plan | SELL | $269K 19.1K sh | Mar 26, 2026 traded Mar 26, 2026 |
| 22 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $272K 19.1K sh | Mar 26, 2026 traded Mar 25, 2026 |
| 18 | Samuelson Errol GChief Industry Dev. Officer | ZANDZGZILLOW GROUP, INC. Open-market sale · 10b5-1 plan | SELL | $209K 4,734 sh | Mar 26, 2026 traded Mar 26, 2026 |
| 16 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $261K 19.1K sh | Mar 26, 2026 traded Mar 24, 2026 |
| 14 | Ugwumba Chidozie10% Owner |  CLNNClene Inc.Open-market sale | SELL | $32K 5,492 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 14 | Ugwumba Chidozie10% Owner | CLNNClene Inc. Open-market sale | SELL | $39K 7,098 sh | Mar 26, 2026 traded Mar 25, 2026 |
| 14 | Bowe Patrick E.Director |  ANDEAndersons, Inc.Open-market sale · 10b5-1 plan | SELL | $1.03M 14.2K sh | Mar 26, 2026 traded Mar 25, 2026 |
| 14 | Ugwumba Chidozie10% Owner | CLNNClene Inc. Open-market sale | SELL | $29K 5,319 sh | Mar 26, 2026 traded Mar 26, 2026 |
| 11 | Colendich Katie MarieGC, Corporate Secretary |  ASANAsana, Inc.Open-market sale · 10b5-1 plan | SELL | $32K 5,015 sh | Mar 26, 2026 traded Mar 25, 2026 |
| 11 | Colendich Katie MarieGC, Corporate Secretary | ASANAsana, Inc. Open-market sale · 10b5-1 plan | SELL | $9,585 1,500 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 11 | Werner Edward CooperChief Financial Officer |  FFIVF5, INC.Open-market sale · 10b5-1 plan | SELL | $300K 1,000 sh | Mar 26, 2026 traded Mar 25, 2026 |
| 8 | Raben DavidChief Medical Officer |  BCAXBicara Therapeutics Inc.Open-market sale · 10b5-1 plan | SELL | $104K 5,500 sh | Mar 26, 2026 traded Mar 25, 2026 |